Abstract

Dopamine transporters (DATs) are members of a family of Na+- and Cl--dependent neurotransmitter transporters responsible for the rapid clearance of dopamine from synaptic clefts. The predicted primary sequence of DAT contains numerous consensus phosphorylation sites. In this report we demonstrate that DATs undergo endogenous phosphorylation in striatal synaptosomes that is regulated by activators of protein kinase C. Rat striatal synaptosomes were metabolically labeled with [32P]orthophosphate, and solubilized homogenates were subjected to immunoprecipitation with an antiserum specific for DAT. Basal phosphorylation occurred in the absence of exogenous treatments, and the phosphorylation level was rapidly increased when synaptosomes were treated with the phosphatase inhibitors okadaic acid or calyculin. Treatment of synaptosomes with the protein kinase C activator phorbol 12-myristate 13-acetate (PMA) also increased the level of phosphate incorporation. This occurred within 10 min and was dosedependent between 0.1 and 1 microM PMA. DAT phosphorylation was also significantly increased by two other protein kinase C activators, (-)-indolactam V and 1-oleoyl-2-acetyl-sn-glycerol. The inactive phorbol ester 4alpha-phorbol 12,13-didecanoate at 10 microM was without effect, and PMA-induced phosphorylation was blocked by treatment of synaptosomes with the protein kinase C inhibitors staurosporine and bisindoylmaleimide. These results indicate that DATs undergo rapid in vivo phosphorylation in response to protein kinase C activation and that a robust mechanism exists in synaptosomes for DAT dephosphorylation. Dopamine transport activity in synaptosomes was reduced by all treatments that promoted DAT phosphorylation, with comparable dose, time, and inhibitor characteristics. The change in transport activity was produced by a reduction in Vmax with no significant effect on the Km for dopamine. These results suggest that synaptosomal dopamine transport activity is regulated by phosphorylation of DAT and present a potential mechanism for local neuronal control of synaptic neurotransmitter levels and consequent downstream neural activity.

Highlights

  • Dopamine transporters (DATs) are members of a family of Na؉- and Cl؊-dependent neurotransmitter transporters responsible for the rapid clearance of dopamine from synaptic clefts

  • In this report we demonstrate that DATs undergo endogenous phosphorylation in striatal synaptosomes that is regulated by activators of protein kinase C

  • DATs were phosphorylated at a basal level in untreated synaptosomes, inclusion of the phosphatase inhibitor okadaic acid (OA) during 32PO4 labeling resulted in a dramatic increase in the level of DAT phosphorylation (Figs. 2 and 6)

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 272, No 24, Issue of June 13, pp. 15541–15546, 1997 Printed in U.S.A. Protein Kinase C-mediated Phosphorylation and Functional Regulation of Dopamine Transporters in Striatal Synaptosomes*. The inactive phorbol ester 4␣phorbol 12,13-didecanoate at 10 ␮M was without effect, and PMA-induced phosphorylation was blocked by treatment of synaptosomes with the protein kinase C inhibitors staurosporine and bisindoylmaleimide. The change in transport activity was produced by a reduction in Vmax with no significant effect on the Km for dopamine These results suggest that synaptosomal dopamine transport activity is regulated by phosphorylation of DAT and present a potential mechanism for local neuronal control of synaptic neurotransmitter levels and consequent downstream neural activity. Treatment of striatal synaptosomes and heterologous expression systems with phorbol esters or other protein kinase activators reduces dopamine transport activity of mouse, rat, and human DATs [15,16,17,18]. Serotonin transport can be acutely modulated by calmodulin in placental choriocarcinoma cells [24], PMA in HEK 293 cells [25], and cGMP and nitric oxide in rat basophilic leukemia cells [26]

Dopamine Transporter Phosphorylation
EXPERIMENTAL PROCEDURES
RESULTS
PMA PMA ϩ bisindoylmaleimide
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call